Google
CDT — CONDUIT PHARMACEUTICALS INC. (Healthcare >> Biotechnology)
CDT FAQ
What is CDT's P/E ratio?
CONDUIT PHARMACEUTICALS INC. (CDT) currently trades at a P/E ratio of 0.08.
What is CDT's ROE?
CONDUIT PHARMACEUTICALS INC. reports a Return on Equity (ROE) of 1.29%.
What is CDT's dividend yield?
CONDUIT PHARMACEUTICALS INC. offers a dividend yield of 0.00%.
What is CDT's Deepscope Quality Score?
Deepscope rates CDT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CDT?
Deepscope's AI Timing Score for CDT is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CDT belong to?
CONDUIT PHARMACEUTICALS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.74
Price
-0.11
(-13.41%)
Day Change
|
|
|---|
CDT, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.16 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.74 |
| PBV / Sector |
N/A / 4.63
|
| Earning Per Share | 3.12 |
| PE / Sector |
0.08 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
2.74 M
GREAT
|
| Average 1W Daily Value |
0.51 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CDT |
| Name | CONDUIT PHARMACEUTICALS INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 4.86 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 3.91 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4581 Tamiami Trail North, Naples, FL, United States, 34103
Phone: 646 491 9132
Website: https://www.cdtequity.com
Sector: Healthcare >> Biotechnology
Description: CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
